Ibrutinib as a potential therapeutic option for HER2...

  • Main
  • 2019 / 8
  • Ibrutinib as a potential therapeutic option for HER2...
Investigational New Drugs 2019 / 8

Ibrutinib as a potential therapeutic option for HER2 overexpressing breast cancer – the role of STAT3 and p21

Prabaharan, Chandra Bose, Yang, Allan Boyao, Chidambaram, Divya, Rajamanickam, Karthic, Napper, Scott, Sakharkar, Meena Kishore
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-019-00837-w
Date:
August, 2019
File:
PDF, 2.60 MB
2019
Conversion to is in progress
Conversion to is failed